MedTrace Logo

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

NCT04799535 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2026-02-03

No results posted yet for this study

Summary

This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.

Conditions

  • Breast Carcinoma
  • Breast Neoplasm

Interventions

PROCEDURE

Ultrasound

Undergo breast ultrasound

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Azra Alizad, M.D. · Mayo Clinic in Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2027-11-29
Completion
2027-11-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04799535 on ClinicalTrials.gov